Annual EBITDA:
-$129.23M-$60.23M(-87.28%)Summary
- As of today, EYPT annual EBITDA is -$129.23 million, with the most recent change of -$60.23 million (-87.28%) on December 31, 2024.
- During the last 3 years, EYPT annual EBITDA has fallen by -$79.08 million (-157.69%).
- EYPT annual EBITDA is now -1140.72% below its all-time high of $12.42 million, reached on June 30, 2010.
Performance
EYPT EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$61.69M-$13.35M(-27.61%)Summary
- As of today, EYPT quarterly EBITDA is -$61.69 million, with the most recent change of -$13.35 million (-27.61%) on June 30, 2025.
- Over the past year, EYPT quarterly EBITDA has dropped by -$27.50 million (-80.46%).
- EYPT quarterly EBITDA is now -393.48% below its all-time high of $21.02 million, reached on September 30, 2014.
Performance
EYPT Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$187.14M-$27.50M(-17.23%)Summary
- As of today, EYPT TTM EBITDA is -$187.14 million, with the most recent change of -$27.50 million (-17.23%) on June 30, 2025.
- Over the past year, EYPT TTM EBITDA has dropped by -$89.41 million (-91.49%).
- EYPT TTM EBITDA is now -1607.14% below its all-time high of $12.42 million, reached on June 30, 2010.
Performance
EYPT TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
EYPT EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -87.3% | -80.5% | -91.5% |
| 3Y3 Years | -157.7% | -233.2% | -174.6% |
| 5Y5 Years | -169.2% | -488.5% | -505.5% |
EYPT EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -157.7% | at low | -331.9% | at low | -163.1% | at low |
| 5Y | 5-Year | -264.1% | at low | -4663.6% | at low | -505.5% | at low |
| All-Time | All-Time | -1140.7% | at low | -393.5% | at low | -1607.1% | at low |
EYPT EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$61.69M(-27.6%) | -$187.14M(-17.2%) |
| Mar 2025 | - | -$48.34M(-8.0%) | -$159.64M(-10.6%) |
| Dec 2024 | -$129.23M(-87.3%) | -$44.77M(-38.4%) | -$144.31M(-24.6%) |
| Sep 2024 | - | -$32.34M(+5.4%) | -$115.78M(-18.5%) |
| Jun 2024 | - | -$34.18M(-3.5%) | -$97.73M(-13.4%) |
| Mar 2024 | - | -$33.02M(-103.3%) | -$86.17M(-15.5%) |
| Dec 2023 | -$69.00M(+28.6%) | -$16.24M(-13.7%) | -$74.60M(+8.0%) |
| Sep 2023 | - | -$14.28M(+36.9%) | -$81.06M(+4.0%) |
| Jun 2023 | - | -$22.63M(-5.5%) | -$84.47M(-5.1%) |
| Mar 2023 | - | -$21.45M(+5.5%) | -$80.35M(-5.0%) |
| Dec 2022 | -$96.62M(-92.7%) | -$22.70M(-28.3%) | -$76.49M(-7.5%) |
| Sep 2022 | - | -$17.69M(+4.5%) | -$71.14M(-4.4%) |
| Jun 2022 | - | -$18.51M(-5.3%) | -$68.15M(-13.7%) |
| Mar 2022 | - | -$17.59M(-1.4%) | -$59.93M(-14.0%) |
| Dec 2021 | -$50.15M(-41.3%) | -$17.35M(-18.1%) | -$52.59M(-11.2%) |
| Sep 2021 | - | -$14.70M(-42.8%) | -$47.31M(-39.5%) |
| Jun 2021 | - | -$10.29M(-0.4%) | -$33.91M(+0.6%) |
| Mar 2021 | - | -$10.25M(+15.1%) | -$34.09M(+1.6%) |
| Dec 2020 | -$35.49M(+26.1%) | -$12.07M(-831.9%) | -$34.64M(-12.1%) |
| Sep 2020 | - | -$1.29M(+87.6%) | -$30.91M(+28.2%) |
| Jun 2020 | - | -$10.48M(+2.9%) | -$43.03M(-2.3%) |
| Mar 2020 | - | -$10.80M(-29.5%) | -$42.06M(+7.1%) |
| Dec 2019 | -$48.01M(-15.0%) | -$8.34M(+37.9%) | -$45.26M(-22.6%) |
| Sep 2019 | - | -$13.41M(-41.0%) | -$36.92M(-57.1%) |
| Jun 2019 | - | -$9.52M(+32.0%) | -$23.51M(-68.0%) |
| Mar 2019 | - | -$13.99M(-136.3%) | -$13.99M(+19.1%) |
| Dec 2018 | -$41.75M(-136.3%) | - | - |
| Jun 2017 | -$17.67M(+15.0%) | -$5.92M(-19.6%) | -$17.29M(+1.6%) |
| Mar 2017 | - | -$4.95M(-3446.6%) | -$17.57M(-0.2%) |
| Dec 2016 | - | $148.00K(+102.3%) | -$17.54M(+22.9%) |
| Sep 2016 | - | -$6.56M(-5.7%) | -$22.74M(-8.4%) |
| Jun 2016 | -$20.79M(-384.7%) | -$6.21M(-26.2%) | -$20.99M(-6.2%) |
| Mar 2016 | - | -$4.92M(+2.7%) | -$19.76M(-0.4%) |
| Dec 2015 | - | -$5.06M(-5.2%) | -$19.68M(-6.2%) |
| Sep 2015 | - | -$4.81M(+3.4%) | -$18.52M(-353.7%) |
| Jun 2015 | $7.30M(+157.7%) | -$4.98M(-2.8%) | $7.30M(-14.1%) |
| Mar 2015 | - | -$4.84M(-24.1%) | $8.50M(-25.1%) |
| Dec 2014 | - | -$3.90M(-118.6%) | $11.35M(-4.3%) |
| Sep 2014 | - | $21.02M(+655.8%) | $11.86M(+193.7%) |
| Jun 2014 | -$12.65M(-14.6%) | -$3.78M(-89.9%) | -$12.65M(-0.4%) |
| Mar 2014 | - | -$1.99M(+41.2%) | -$12.60M(+4.3%) |
| Dec 2013 | - | -$3.39M(+2.8%) | -$13.17M(-8.1%) |
| Sep 2013 | - | -$3.49M(+6.6%) | -$12.18M(-10.4%) |
| Jun 2013 | -$11.04M | -$3.73M(-45.6%) | -$11.04M(-18.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2013 | - | -$2.56M(-6.9%) | -$9.34M(-0.8%) |
| Dec 2012 | - | -$2.40M(-2.4%) | -$9.27M(-5.1%) |
| Sep 2012 | - | -$2.34M(-14.9%) | -$8.82M(-8.2%) |
| Jun 2012 | -$22.78M(-315.8%) | -$2.04M(+18.1%) | -$8.15M(-46.4%) |
| Mar 2012 | - | -$2.49M(-27.7%) | -$5.57M(-3.6%) |
| Dec 2011 | - | -$1.95M(-16.5%) | -$5.37M(+5.9%) |
| Sep 2011 | - | -$1.67M(-406.0%) | -$5.71M(+14.1%) |
| Jun 2011 | -$5.48M(-144.1%) | $547.00K(+123.8%) | -$6.65M(-215.0%) |
| Mar 2011 | - | -$2.29M(-0.4%) | $5.78M(-4.2%) |
| Dec 2010 | - | -$2.29M(+12.5%) | $6.03M(-33.4%) |
| Sep 2010 | - | -$2.61M(-120.1%) | $9.06M(-27.1%) |
| Jun 2010 | $12.42M(>+9900.0%) | $12.97M(+736.0%) | $12.42M(+5757.1%) |
| Mar 2010 | - | -$2.04M(-377.2%) | $212.00K(-90.6%) |
| Dec 2009 | - | $736.00K(-1.5%) | $2.27M(+136.3%) |
| Sep 2009 | - | $747.00K(-2.9%) | $959.00K(+180.1%) |
| Jun 2009 | -$24.00K(+100.0%) | $769.00K(+5392.9%) | -$1.20M(+79.9%) |
| Mar 2009 | - | $14.00K(+102.5%) | -$5.97M(+48.4%) |
| Dec 2008 | - | -$571.00K(+59.5%) | -$11.57M(+35.5%) |
| Sep 2008 | - | -$1.41M(+64.8%) | -$17.93M(+13.1%) |
| Jun 2008 | -$71.36M(-166.0%) | -$4.01M(+28.2%) | -$20.62M(+61.8%) |
| Mar 2008 | - | -$5.58M(+19.4%) | -$53.93M(-11.7%) |
| Dec 2007 | - | -$6.93M(-68.9%) | -$48.29M(+3.2%) |
| Sep 2007 | - | -$4.10M(+89.0%) | -$49.86M(-10.9%) |
| Jun 2007 | -$26.82M(-41.4%) | -$37.32M(>-9900.0%) | -$44.97M(-23.6%) |
| Mar 2007 | - | $65.00K(+100.8%) | -$36.38M(-0.8%) |
| Dec 2006 | - | -$8.50M(-1175.4%) | -$36.09M(-34.1%) |
| Sep 2006 | - | $790.40K(+102.8%) | -$26.92M(+1.5%) |
| Jun 2006 | -$18.98M(-101.1%) | -$28.73M(-8264.7%) | -$27.33M(-100.5%) |
| Mar 2006 | - | $351.90K(-47.5%) | -$13.63M(+1.4%) |
| Dec 2005 | - | $670.70K(+78.8%) | -$13.82M(+3.6%) |
| Sep 2005 | - | $375.10K(+102.5%) | -$14.33M(+1.5%) |
| Jun 2005 | -$9.44M(-57.4%) | -$15.03M(-9470.5%) | -$14.56M(-143.3%) |
| Mar 2005 | - | $160.40K(-0.9%) | -$5.98M(+1.4%) |
| Dec 2004 | - | $161.80K(+7.4%) | -$6.07M(+1.5%) |
| Sep 2004 | - | $150.70K(+102.3%) | -$6.16M(+1.4%) |
| Jun 2004 | -$6.00M(-77.1%) | -$6.46M(-8954.7%) | -$6.25M(-81.7%) |
| Mar 2004 | - | $72.90K(+1.5%) | -$3.44M(+1.6%) |
| Dec 2003 | - | $71.80K(+10.6%) | -$3.49M(+1.6%) |
| Sep 2003 | - | $64.90K(+101.8%) | -$3.55M(+1.4%) |
| Jun 2003 | -$3.39M(-164.7%) | -$3.65M(>-9900.0%) | -$3.60M(-7728.4%) |
| Mar 2003 | - | $16.70K(+7.7%) | $47.20K(+54.8%) |
| Dec 2002 | - | $15.50K(+3.3%) | $30.50K(+103.3%) |
| Sep 2002 | - | $15.00K | $15.00K |
| Jun 2002 | -$1.28M(-194.2%) | - | - |
| Jun 2001 | -$434.60K | - | - |
FAQ
- What is EyePoint Pharmaceuticals, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for EyePoint Pharmaceuticals, Inc.?
- What is EyePoint Pharmaceuticals, Inc. annual EBITDA year-on-year change?
- What is EyePoint Pharmaceuticals, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for EyePoint Pharmaceuticals, Inc.?
- What is EyePoint Pharmaceuticals, Inc. quarterly EBITDA year-on-year change?
- What is EyePoint Pharmaceuticals, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for EyePoint Pharmaceuticals, Inc.?
- What is EyePoint Pharmaceuticals, Inc. TTM EBITDA year-on-year change?
What is EyePoint Pharmaceuticals, Inc. annual EBITDA?
The current annual EBITDA of EYPT is -$129.23M
What is the all-time high annual EBITDA for EyePoint Pharmaceuticals, Inc.?
EyePoint Pharmaceuticals, Inc. all-time high annual EBITDA is $12.42M
What is EyePoint Pharmaceuticals, Inc. annual EBITDA year-on-year change?
Over the past year, EYPT annual EBITDA has changed by -$60.23M (-87.28%)
What is EyePoint Pharmaceuticals, Inc. quarterly EBITDA?
The current quarterly EBITDA of EYPT is -$61.69M
What is the all-time high quarterly EBITDA for EyePoint Pharmaceuticals, Inc.?
EyePoint Pharmaceuticals, Inc. all-time high quarterly EBITDA is $21.02M
What is EyePoint Pharmaceuticals, Inc. quarterly EBITDA year-on-year change?
Over the past year, EYPT quarterly EBITDA has changed by -$27.50M (-80.46%)
What is EyePoint Pharmaceuticals, Inc. TTM EBITDA?
The current TTM EBITDA of EYPT is -$187.14M
What is the all-time high TTM EBITDA for EyePoint Pharmaceuticals, Inc.?
EyePoint Pharmaceuticals, Inc. all-time high TTM EBITDA is $12.42M
What is EyePoint Pharmaceuticals, Inc. TTM EBITDA year-on-year change?
Over the past year, EYPT TTM EBITDA has changed by -$89.41M (-91.49%)